No Prescription » Prescription Drugs 10 » Maximune Invirase
Saquinavir is not a cure for HIV and it does not prevent the spread of HIV to others through sexual contact or blood contamination (e.g. sharing used needles).OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication may also be used to prevent HIV infection after contact with the virus.How to use Saquinavir OralTake this medication by mouth with a meal or up to 2 hours after a meal usually 2-3 times daily or as directed by your doctor.The dosage is based on your weight liver function medical condition other medications and response to therapy.It is very important to continue taking this medication (and other HIV medications) exactly as prescribed by your doctor.This medication works best when the amount of drug in your body is kept at a constant level. Therefore take this drug at evenly spaced intervals. To help you remember use it at the same times each day.Do not take more or less of this drug than prescribed or stop taking it (or other HIV medicines) even for a short time unless directed to do so by your doctor. Skipping or changing your dose without approval from your doctor may cause the amount of virus to increase make the infection more difficult to treat (resistant) or worsen side effects.Saquinavir Oral is used to treat the following:HIVSaquinavir Oral may also be used to treat:Prevention of HIV Infection after Exposure
Buy Maximune Invirase and other Prescription Drugs 10 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Maximune Invirase:
Product Type: Prescription Drugs 10
Maximune ( Invirase Generic Saquinavir )
Maximune (Invirase Generic Saquinavir)
Invirase Generic Saquinavir
200mg
Invirase Generic Saquinavir Maximune

View more
Prescription Drugs 10
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|